	Contrast-enhanced harmonic endoscopic ultrasonography (EUS)-guided tissue acquisition significantly improves diagnostic yield for small liver metastases derived from pancreatic cancer: a prospective study. Pancreatology Emori T, Itonaga M, Ashida R, Nakahata A, Tamura T, Kawaji Y, Tamura T, Yamashita Y, Fukatsu K, Shimokawa T, Kitano M. PMID: 41392004 [PubMed - as supplied by publisher]
	Emerging nanoparticle-based therapies for pancreatic cancer: Current clinical landscape. Adv Drug Deliv Rev Salgado A, Zalba S, Lasarte JJ, Garrido MJ. PMID: 41391820 [PubMed - as supplied by publisher]
	ASO Visual Abstract: Neoadjuvant Treatment is a Risk Factor for Clinically Relevant Chyle Leak (ISGPS Grade B/C) after Pancreatic Cancer Resection: A Retrospective Cohort Study. Ann Surg Oncol Leonhardt CS, Shraim S, Abdelazim K, Hinz U, Polychronidis G, Hank T, Schneider M, Hackert T, Strobel O, Loos M, Buechler MW, Al-Saeedi M. PMID: 41390552 [PubMed - as supplied by publisher]
	BAG6 promotes hepatocellular carcinoma growth via enhancing PLK1-mediated aerobic glycolysis. Int J Biol Macromol Zhang W, Du D, Lu H, Zhang W, Lei J. PMID: 41390024 [PubMed - as supplied by publisher]
	Treatment landscape from first- to third-line therapy and quality of life data of patients with pancreatic cancer from the prospective German PARAGON (Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer) registry (IKF-PARAGON study). Int J Cancer Goetze TO, Al-Batran SE, Liersch R, Scheuer L, Goehler T, Kaiser U, Denzlinger C, Brandl S, Pink D, Uhlig J, Maasberg M, Loose M, Schaaf M, Sookthai D, Zäpf B, Pauligk C, Habibzade T, Hofheinz RD, Koch C, AIO Study Group. PMID: 41388765 [PubMed - as supplied by publisher]
	Deep learning to predict extrapancreatic perineural invasion at CT images. Ann Med Cai Z, Zou L, Li Q, Chen J, Qiu Y, Ji J, Mao L. PMID: 41388696 [PubMed - indexed for MEDLINE]
	A prospective observational study of pancreatic cancer risk in men and women with pathogenic variants in BRCA1 or BRCA2. BJC Rep Grindedal EM, Zucknick M, Hovland ST, Grimsrud TK, Mæhle L. PMID: 41387549 [PubMed]
	Nutrition in Hepatocellular Carcinoma: Pathophysiological Insights, Impact, and Implications for Clinical Practice. J Gastroenterol Hepatol Dirjayanto VJ, Yiu DSM, Chen R, Fan KH. PMID: 41387249 [PubMed - as supplied by publisher]
	Association between pancreatic enzyme replacement therapy and mortality in pancreatic cancer: a matched case-control study. Pancreatology Dugic A, Hagström H, Palmer I, Nouri A, Tari HT, Schmaderer L, Liljefors MG, Ghorbani P, Löhr JM, Vujasinovic M. PMID: 41387158 [PubMed - as supplied by publisher]
	The tumor microbiome and cancer immunotherapy: A systematic review of a new frontier beyond the gut. Bull Cancer Barjij I, Meliani M. PMID: 41387030 [PubMed - as supplied by publisher]
	Comparative Analysis of Fecal Microbiota in Healthy Controls and Pancreatic Cancer Patients: A Focus on Tumor Localization Differences in Pancreatic Head and Body-Tail. Cancer Med Villani A, Mencarelli G, Cocomazzi G, Binda E, Virgili E, Latiano TP, Maiello E, Contu V, Perri F, Panebianco C, Pazienza V. PMID: 41386285 [PubMed - indexed for MEDLINE]
	Cancer incidence, stage at diagnosis, and trends across the Navajo Nation, 2014-2018. Cancer Yazzie D, Pete D, Briscoe C, Jim MA, Meisner A, Wiggins C, Doyle D, Yee G, Goldtooth C, Sanderson PR, Keene CN, Smith M, Sehn H, Damon S, Kettering CL, Emerson M, Curley C, Bea J, Yazzie S, Joe N, Doherty J, Dirk de Heer H, Navajo Cancer Workgroup. PMID: 41385397 [PubMed - indexed for MEDLINE]
	A review, evaluation and content mapping study of Australian patient-facing online pancreatobiliary cancer resources. Support Care Cancer Ferrar K, Baggoley C, Beatty L, Brooke-Smith M, Han CY, Holz B, Koczwara B, Lee J, Paterson C, Wallen MP, Robertson A, Barreto SG. PMID: 41385087 [PubMed - indexed for MEDLINE]
	Large Language Model-Based Automated Tumor, Node, Metastasis Staging and Resectability Assessment for Pancreatic Cancer in Radiology Reports With Detection of Incomplete Documentation. Cureus Fujisawa S, Kurokawa R, Hagiwara A, Kurokawa M, Asari Y, Hatano S, Matsumoto D, Negishi A, Gonoi W, Abe O. PMID: 41384206 [PubMed]
	Compare the prognosis of pancreatic cancer patients with different treatment modalities and use machine learning methods to build predictive models. Front Med (Lausanne) Fan L, Kong S, Deng Y, Wang Y, Yan X, Jiang C, Tao L, Wang W. PMID: 41384105 [PubMed]
	Preoperative TACE with PD-1 inhibitors and TKIs in beyond "up-to-seven" hepatocellular carcinoma: a propensity score matched analysis. Front Immunol Zhong D, Liang Y, Chen Y, Su Y, Yang Q, Yan H, Huang X, Wang M. PMID: 41383585 [PubMed - indexed for MEDLINE]
	Letter to editor "A deep learning-based clinical-radiomics model predicting the treatment response of immune checkpoint inhibitors (ICIs)-based conversion therapy in potentially convertible hepatocellular carcinoma patients: a tumor marker prognostic study". Int J Surg Wang B, Shen N, Xiao H. PMID: 41382402 [PubMed - in process]
	Neoadjuvant therapy versus upfront surgery for resectable pancreatic cancer: Updated systematic review, individual-patient-data meta-analysis and trial sequential analysis of randomized controlled trials. Surgery Tan HL, Zhao Y, Chua DW, Ng KYY, Lee SY, Lee JJX, Tai DW, Goh BKP, Koh YX. PMID: 41381268 [PubMed - as supplied by publisher]
	Harnessing the effector-to-regulatory T cell ratio to advance prognosis and precision therapy in pancreatic cancer. Crit Rev Oncol Hematol Guo X, Zhang H, Yao L, Ma W. PMID: 41380868 [PubMed - as supplied by publisher]
	The dual role of miR-184 in cancer: a systematic review of context-dependent regulation. Mol Biol Rep Duff B, Swadi R. PMID: 41379397 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 58475

Page 1 of 2924



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy